Back to Search
DR. JOHN CHRISTOPHER GRAYBILL M.D.
M.D.
Trauma Surgery Physician
NPI: 1033312863IndividualAccepts Medicare
Specialties, Licenses & Credentials
Trauma Surgery PhysicianPrimary
Surgery — Trauma Surgery
Code: 2086S0127X
0101240898(VA)D0102165(MD)
Surgical Critical Care Physician
Surgery — Surgical Critical Care
Code: 2086S0102X
0101240898(VA)
Surgery Physician
Surgery
Code: 208600000X
0101240898(VA)
Education
OTHER
Class of 2005
Research & Publications (20)
Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region.
PMID 19409759·Int J Antimicrob Agents·2009
8-other
Inhaled voriconazole for prevention of invasive pulmonary aspergillosis.
PMID 19289523·Antimicrob Agents Chemother·2009
7-preclinical
Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.
PMID 18474582·Antimicrob Agents Chemother·2008
7-preclinical
Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice.
PMID 18397335·Clin Microbiol Infect·2008
7-preclinical
Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis.
PMID 18160526·Antimicrob Agents Chemother·2008
7-preclinical
Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment.
PMID 18835806·J Antimicrob Chemother·2008
3-trial
Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
PMID 18813103·Transplantation·2008
8-other
The north and south of candidemia: Issues for Latin America.
PMID 18810276·Drugs Today (Barc)·2008
6-review
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.
PMID 18637757·Clin Infect Dis·2008
6-review
Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.
PMID 18658194·J Antimicrob Chemother·2008
4-observational
Voriconazole in the treatment of fungal eye infections: a review of current literature.
PMID 18577634·Br J Ophthalmol·2008
6-review
Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
PMID 17243069·Clin Infect Dis·2007
3-trial
Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.
PMID 17360039·J Infect·2007
7-preclinical
Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance.
PMID 17980231·Am J Infect Control·2007
6-review
New guinea pig model of Cryptococcal meningitis.
PMID 17562797·Antimicrob Agents Chemother·2007
7-preclinical
In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera.
PMID 17307976·Antimicrob Agents Chemother·2007
7-preclinical
Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance.
PMID 17602911·Am J Med·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 1800 ORLEANS ST
BALTIMORE, MD 21287 - Phone
- (410) 502-2037
Quick Facts
- NPI
- 1033312863
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 3
- Years in Practice
- 21
- Publications
- 20
Are you this provider?
Claim Your Profile